Health

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi

  • by

Pharmaceutical companies insist secrecy is the only way. But what if they were obliged to share recipes and supply chains? Biolyse is a small pharmaceutical manufacturer in Canada with a simple proposition: provide a recipe for a coronavirus vaccine, and it will produce 20m doses… Read More »The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

  • by

Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has… Read More »EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

  • by

Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health… Read More »What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

Medicines watchdog says no decision made AstraZeneca jab for under-30s

  • by

Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca… Read More »Medicines watchdog says no decision made AstraZeneca jab for under-30s

AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data

  • by

Worldwide focus on Covid-19 means a ‘minor issue’ is getting media attention, experts say Australia’s Covid vaccine rollout would be ‘dire’ without local AstraZeneca production, health chief says Australia’s drug regulator, the Therapeutic Goods Administration, has dismissed questions raised about “outdated information” in AstraZeneca vaccine… Read More »AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

  • by

The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering… Read More »At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

Oxford Covid vaccine 10% effective against South African variant, study suggests

  • by

Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have… Read More »Oxford Covid vaccine 10% effective against South African variant, study suggests

CBD will go on sale in Australia, but first manufacturers will have to prove it works

  • by

While CBD has been approved for over-the-counter sale, there are regulatory hurdles to clear before it actually appears in pharmacies “You can have as much whiskey as you like, but there’s no whiskey available,” says Prof Iain McGregor, psychopharmacologist and academic director of the Lambert… Read More »CBD will go on sale in Australia, but first manufacturers will have to prove it works

Celltrion Receives Health Canada’s Approval for Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis

  • by

Shots: The Health Canada has granted a NOC which is based on clinical evidence for Remsima/CT-P13 SC vs CT-P13 IV up to 1year in patients with RA. The results demonstrated that switching patients from Remsima IV to its SC formulation @30wks. is comparable to maintaining… Read More »Celltrion Receives Health Canada’s Approval for Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis

World’s poor need action, not Covid ‘vaccine nationalism’, say experts

  • by

Nations outbidding each other creates an ‘immoral race towards the abyss’ Coronavirus – latest updates See all our coronavirus coverage Pharmaceutical companies should do more to transfer vaccine technology to prevent the poorest countries falling behind in the distribution of Covid-19 vaccines, according to an… Read More »World’s poor need action, not Covid ‘vaccine nationalism’, say experts

Single Covid vaccine dose in Israel ‘less effective than we hoped’

  • by

Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNtech vaccine may be providing less protection than originally hoped, as the country reported a… Read More »Single Covid vaccine dose in Israel ‘less effective than we hoped’

Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns

  • by

Australia has secured 54m doses of the vaccine some experts say is inferior to Pfizer’s mRNA vaccine, which Australia has bought just 10m doses of Covid hotspots Victoria; NSW hotspots; Queensland hotspots NSW and Sydney trend map: where cases are rising or falling Follow the… Read More »Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty

  • by

The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security risk’ Everything now hinges on a vaccine: how many more Britons die, whether the NHS finally breaks, how long the… Read More »Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty

Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women’s Health

  • by

Shots: Myovant & Pfizer will jointly develop & commercialize ORGOVYX (relugolix) in advanced prostate cancer & if approved, relugolix combination tablet in women’s health in the US & Canada. Myovant will receive ~$4.2B including $650M upfront, $200M in regulatory milestones for FDA approvals for relugolix… Read More »Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women’s Health

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers

  • by

Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all our coronavirus coverage A Belgian minister has inadvertently blown the lid off a sensitive and commercial secret – the price… Read More »Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

  • by

Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology… Read More »Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

  • by

Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has… Read More »BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

A vaccine revolution | podcast

  • by

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach? After a gruelling year of successive waves of Covid-19… Read More »A vaccine revolution | podcast

Lilly’s Bamlanivimab (LY-CoV555) Receives Health Canada’s Interim Authorization as a Treatment for COVID-19

  • by

Shots: The authorization is based on P-II BLAZE-1 study assessing the efficacy and safety of bamlanivimab (700/2800/7000 mg) alone or in combination with a second Ab vs PBO for the treatment of symptomatic COVID-19 in the outpatient setting Results: reduction in viral load & rates… Read More »Lilly’s Bamlanivimab (LY-CoV555) Receives Health Canada’s Interim Authorization as a Treatment for COVID-19

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial

  • by

Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They noted how such stories spread through communities, “infecting” some individuals while others seemed immune, and how more resistant populations could… Read More »The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff

  • by

To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See all our coronavirus coverage Lydia Guthrie is not very daring by nature. A psychotherapist and mother of two from Oxford,… Read More »It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff

The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones

  • by

The pharmaceutical industry has long made exorbitant profits by free-riding on research carried out by the public sector Hooray for Pfizer! As news of a vaccine potentially offering 90% protection against Covid-19 offers a life raft for lockdown-weary humanity, perhaps those home-drawn posters on people’s… Read More »The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury

  • by

Despite the Pfizer breakthrough, social distancing and remote working won’t disappear overnight Coronavirus – latest updates See all our coronavirus coverage The news this week that the Pfizer/BioNTech vaccine protected more than 90% of recipients is of huge importance. The vaccine efficacy is higher than… Read More »Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury

Novartis’s Luxturna (voretigene neparvovec) Receives Health Canada Approval as the First Gene Replacement Therapy for Inherited Retinal Disease

  • by

Shots: Health Canada has approved Luxturna (voretigene neparvovec) as a one-time gene therapy for the treatment of adult & pediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells Luxturna is designed… Read More »Novartis’s Luxturna (voretigene neparvovec) Receives Health Canada Approval as the First Gene Replacement Therapy for Inherited Retinal Disease

Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes

  • by

Healthcare workers and health departments will be among the first to use the rapid antigen tests Full Australian Covid stats; Covid restrictions state by state Follow our global live blog Vic cases map; NSW cases map NSW hotspots list; Qld hotspots list Australia’s drugs regulator… Read More »Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

  • by

Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot,… Read More »Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant

  • by

A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development The development of a promising Covid-19 vaccine has been put on hold due to a possible adverse reaction in a trial participant. A spokesman for AstraZeneca,… Read More »Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant

Honey better treatment for coughs and colds than antibiotics, study claims

  • by

Research suggests honey also more effective than many over-the-counter medicines Honey may be better than conventional treatments for coughs, blocked noses and sore throats, researchers have said. The substance is cheap, readily available, and has virtually no side-effects. Doctors can recommend it as a suitable… Read More »Honey better treatment for coughs and colds than antibiotics, study claims

‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi

  • by

Russia is not the only country pursuing domestic politics over global cooperation in the fight against coronavirus We’re all waiting for a coronavirus vaccine, but when Russia announced earlier this week that it would be the first country to approve one, nobody rejoiced. Scientists pointed… Read More »‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi

Australia experiencing critical shortage of antidepressants, contraceptives and HRT

  • by

Reasons for shortages are often unclear and substitutes, which are not subsidised by PBS, are prohibitively expensive Australia is experiencing a critical shortage of key drugs including antidepressants, contraceptives and hormone replacement therapies, a situation that experts say highlights systemic problems with medicine supply in… Read More »Australia experiencing critical shortage of antidepressants, contraceptives and HRT

Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize

  • by

Cumberlege report is a damning reminder of how arrogant, intimidating doctors have suppressed their patients’ views Julia Cumberlege’s report into avoidable harm inflicted by the healthcare system exposes an institutional inability to listen to patients in general and women in particular. Her investigation into decades… Read More »Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize

The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney

We need a public register to show if healthcare professionals are in the pay of industry – or more patients will suffer It was never “just women’s problems”. After decades of having their suffering dismissed, many patients will have been relieved about the publication of… Read More »The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney

Thanks to a new drug for cystic fibrosis, I can plan a future I thought I’d never have | Isabelle Jani-Friend

With the NHS deal on Kaftrio, I’m likely to live longer. This is why swift access to novel treatments is so important It’s been 15 weeks since I went into isolation to shield from Covid-19 – having cystic fibrosis (CF) put me in the high-risk… Read More »

Thanks to a new drug for cystic fibrosis, I can plan a future I thought I’d never have | Isabelle Jani-Friend

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients… Read More »

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Australian drugmakers hit by critical shortages at height of pandemic, inquiry hears

  • by

Evidence given to parliamentary committee sparks new calls to develop national capability to manufacture medicines and key supplies Australian companies were “shocked” to experience price-gouging and had trouble accessing critical supplies to make medicines and personal protective equipment at the height of the pandemic, a… Read More »Australian drugmakers hit by critical shortages at height of pandemic, inquiry hears

How will the world’s poorest people get a coronavirus vaccine? | Achal Prabhala and Kate Elder

  • by

Rich countries’ governments are putting all their trust in a marriage of markets and philanthropy called Gavi Vaccines for Covid-19 are coming. Billions of dollars are flowing in, over 100 efforts are under way, and at least 13 leading candidates are already being tested on… Read More »

How will the world’s poorest people get a coronavirus vaccine? | Achal Prabhala and Kate Elder

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

  • by

Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government decisions Coronavirus – latest updates See all our coronavirus coverage There is a school of thought that says now is… Read More »

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

TEDMED 2020 Meetups

  • by

TEDMED Meetups, uniquely designed conversations, engage the entire TEDMED community to share their individual perspectives and voices to help improve humanity’s health. Read on to view some of the details of these captivating conversations taking place at TEDMED 2020. Meetup 1 Tuesday, March 3rd, 8:00… Read More »TEDMED 2020 Meetups

10 tips for cultivating wellbeing

  • by

What is wellbeing? I would describe wellbeing as the holistic experience of feeling energised, comfortable, connected and inspired. Our personal wellbeing is cultivated by all the unconditionally kind, wise and compassionate choices we make to nurture our health and happiness. These choices encompass our thoughts… Read More »10 tips for cultivating wellbeing